AKT1 and hepatocellular carcinoma: Schmitz et al. [18] have reported that p-ERK1/2 and p-Akt(ser473) are both highly expressed in HCC tissues, and that the activation of the ERK and AKT pathways predicts poor prognosis in HCC.